# Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia

> **NCT06560879** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **National Institute of Pediatrics, Mexico** · enrollment: 120 (estimated)

## Conditions studied

- Probiotics
- Gastrointestinal Diseases
- Precursor Cell Lymphoblastic Leukemia-Lymphoma

## Interventions

- **BIOLOGICAL:** Lactobacillus casei
- **BIOLOGICAL:** Lactobacillus rhamnosus
- **BIOLOGICAL:** Bifidobacterium bifidum
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06560879
- **Lead sponsor:** National Institute of Pediatrics, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-02-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06560879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06560879, "Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06560879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*